Outcome of Board meeting to consider audited financial results are submitted herewith
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Hindustan Organic Chemicals (HOCL), a Government of India enterprise, approved audited standalone and consolidated results for Q4 and FY25 on 16 May 2025. Standalone revenue from operations fell to Rs 535.87 crore in FY25 from Rs 703.89 crore in FY24, a decline of roughly 24%. The company reported a standalone net profit of Rs 519.68 crore for FY25 versus a loss of Rs 78.77 crore in FY24, almost entirely driven by a one-time exceptional gain of Rs 502.75 crore. This came from the Government of India waiving GOI loans (Rs 435.86 crore), redeemable preference shares (Rs 270 crore), accrued interest (Rs 473.60 crore) and contingent penal interest (Rs 98.68 crore), totaling about Rs 1,278 crore. Excluding this exceptional item, core operations remained in a Rs 55.32 crore loss, although narrower than the Rs 107.88 crore operating loss last year. The auditor issued an unmodified opinion but flagged emphasis of matter on the GOI waiver, the non-functional audit committee (no independent directors), SEBI LODR non-compliance on board composition, and going concern assumptions.
Headline profit is a one-time accounting event from government debt forgiveness rather than improved operations; underlying business continues to lose money on a like-for-like basis. Shrinking revenue and lack of an active audit committee are governance red flags, though the debt waiver significantly cleans up the balance sheet going forward.